MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review.

EMBO Molecular Medicine
Marilena V Iorio, Carlo M Croce

Abstract

Early studies have shown how aberrantly expressed microRNAs are a hallmark of several diseases like cancer. MicroRNA expression profiling was shown to be associated with tumour development, progression and response to therapy, suggesting their possible use as diagnostic, prognostic and predictive biomarkers. Moreover, based on the increasing number of studies demonstrating that microRNAs can function as potential oncogenes or oncosuppressor genes, with the goal to improve disease response and increase cure rates, miRNA-based anticancer therapies have recently been exploited, either alone or in combination with current targeted therapies. The advantage of using microRNA approaches is based on its ability to concurrently target multiple effectors of pathways involved in cell differentiation, proliferation and survival. Here, we review our current knowledge about the involvement of microRNAs in cancer, and their potential as diagnostic, prognostic and therapeutic tools.

References

Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Oct 27, 2001·Science·M Lagos-QuintanaT Tuschl
Nov 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·George Adrian CalinCarlo M Croce
Jan 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·Gustavo TiscorniaInder M Verma
Dec 19, 2003·Genes & Development·Rui YiBryan R Cullen
Feb 20, 2004·Proceedings of the National Academy of Sciences of the United States of America·George Adrian CalinCarlo M Croce
Mar 17, 2004·PLoS Biology·György HutvágnerPhillip D Zamore
Jun 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Chang-Gong LiuCarlo M Croce
Sep 17, 2004·The EMBO Journal·Yoontae LeeV Narry Kim
Feb 22, 2005·PLoS Biology·Julius BrenneckeStephen M Cohen
Feb 23, 2005·Cancer Science·Yoko KarubeTakashi Takahashi
Mar 16, 2005·Cell·Steven M JohnsonFrank J Slack
Apr 5, 2005·Nature Genetics·Azra KrekNikolaus Rajewsky
Jun 10, 2005·Nature·Lin HeScott M Hammond
Jun 10, 2005·Nature·Jun LuTodd R Golub
Jul 19, 2005·Cancer Research·Jennifer A ChanKenneth S Kosik
Jul 26, 2005·Biochemical and Biophysical Research Communications·S A CiafrèM G Farace
Aug 17, 2005·Cancer Research·Marilena V IorioCarlo M Croce
Sep 17, 2005·Proceedings of the National Academy of Sciences of the United States of America·Amelia CimminoCarlo M Croce
Oct 28, 2005·The New England Journal of Medicine·George Adrian CalinCarlo M Croce
Nov 1, 2005·Nature·Jan KrützfeldtMarkus Stoffel
Nov 30, 2005·Nucleic Acids Research·Caifu ChenKarl J Guegler
Dec 24, 2005·RNA·Praveen SethupathyArtemis G Hatzigeorgiou
Dec 31, 2005·Nucleic Acids Research·Paul W C HsuIvo L Hofacker
Jan 24, 2006·Blood Reviews·Oliver GalmStephen B Baylin
Feb 3, 2006·Cancer Research·Gary K ScottChristopher C Benz
Feb 7, 2006·Cell Metabolism·Christine EsauBrett P Monia
Feb 8, 2006·Proceedings of the National Academy of Sciences of the United States of America·Stefano VoliniaCarlo M Croce
Mar 15, 2006·Cancer Cell·Nozomu YanaiharaCurtis C Harris
Apr 28, 2006·Proceedings of the National Academy of Sciences of the United States of America·Stefan CostineanCarlo M Croce
Jun 7, 2006·Proceedings of the National Academy of Sciences of the United States of America·Lin ZhangGeorge Coukos
Jul 20, 2006·Blood·Laura PolisenoGiuseppe Rainaldi
Aug 1, 2006·Nature Genetics·Michael DewsAndrei Thomas-Tikhonenko
Aug 3, 2006·Genes & Development·J Michael ThomsonScott M Hammond
Oct 25, 2006·Nature Reviews. Cancer·George A Calin, Carlo M Croce

❮ Previous
Next ❯

Citations

Jun 21, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Julie Bienertova-VaskuOndrej Slaby
Jul 9, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Wei LiDan Luo
Jul 3, 2013·Best Practice & Research. Clinical Gastroenterology·Matteo FassanAndrás Kiss
Sep 21, 2013·Trends in Molecular Medicine·Tao YangMansour Mohamadzadeh
Mar 14, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Flavie SicardPierre Cordelier
Jul 4, 2012·Nature Reviews. Gastroenterology & Hepatology·Elaine R Mardis
Nov 21, 2012·Nature Reviews. Gastroenterology & Hepatology·Shumei Song, Jaffer A Ajani
Apr 12, 2012·Carcinogenesis·Marilena V Iorio, Carlo M Croce
Jun 5, 2013·Neuro-oncology·Pierpaolo PeruzziJakub Godlewski
Oct 12, 2012·Toxicological Sciences : an Official Journal of the Society of Toxicology·Yun TengCarolyn M Klinge
Jan 24, 2013·Current Opinion in Otolaryngology & Head and Neck Surgery·Hsi-Feng TuKuo-Wei Chang
Jun 1, 2012·The Cancer Journal·Marilena V Iorio, Carlo M Croce
Sep 20, 2012·Journal of Gastroenterology and Hepatology·Yizhou ZhangKazuaki Chayama
Feb 22, 2013·The Journal of Clinical Investigation·Sichuan XiDavid S Schrump
Jan 17, 2013·Journal of Hematology & Oncology·Yu-Meng SunYue-Qin Chen
Jan 1, 2014·Genome Medicine·Carlos Stahlhut, Frank J Slack
Mar 2, 2013·PloS One·Naduparambil Korah JacobArnab Chakravarti
Sep 17, 2013·PloS One·Christiane MargueStephanie Kreis
Apr 8, 2014·PloS One·Hiroko Ogata-KawataNaoto Tsuchiya
Dec 4, 2012·International Journal of Molecular Sciences·Joy TangFazlul H Sarkar
Jul 16, 2013·International Journal of Molecular Sciences·Alessandro Rosa, Ali H Brivanlou
Jul 19, 2013·International Journal of Molecular Sciences·Daniela SchwarzenbacherMartin Pichler
Dec 7, 2013·World Journal of Gastroenterology : WJG·Sara De IudicibusGiuliana Decorti
Aug 2, 2013·International Journal of Biological Sciences·Qingping MaWen Zhu
Jan 8, 2014·Theranostics·Amanda TufmanRudolf Maria Huber
Apr 26, 2014·World Journal of Gastroenterology : WJG·Jing-Jia Ye, Jiang Cao
Jul 25, 2013·Antioxidants & Redox Signaling·Guohui WanXiongbin Lu
Jan 21, 2014·Molecular and Cellular Endocrinology·J BoguslawskaA Nauman
Jun 19, 2012·Toxicological Sciences : an Official Journal of the Society of Toxicology·Janani SaikumarVishal S Vaidya

❮ Previous
Next ❯

Methods Mentioned

BETA
chromosomal aberrations
antisense oligonucleotide
PCR
acetylation
pull-down
immunoprecipitation
antisense oligonucleotides
xenograft
chemical

Clinical Trials Mentioned

NCT00688012

Software Mentioned

miRNome

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Carcinogenesis
Marilena V Iorio, Carlo M Croce
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Marilena V Iorio, Carlo M Croce
© 2022 Meta ULC. All rights reserved